Amylyx Pharmaceuticals Inc (AMLX)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

AMLX logo

AMLX Cost of Revenue

Latest reported$0.00
AMLX Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

AMLX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amylyx Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
98,000
108,000
19,855,000
141,000
22,119,000
0
809,000
7,626,000
116,406,000
9,360,000
5,218,000
5,580,000
5,283,000
2,821,000
172,000
0
21,464,000
13,394,000
0
10,929,000
6,864,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.